NCT03783143View on ClinicalTrials.gov

Prevalence and Incidence of Lassa Virus Infection in Southern Mali

CompletedOBSERVATIONAL
Enrollment

8,524

Participants

Timeline

Start Date

December 4, 2020

Primary Completion Date

July 25, 2024

Study Completion Date

July 25, 2024

Conditions
Lassa Virus Infection
Trial Locations (1)

Unknown

Icer/Mrtc/Fmos/Usttb, Bamako

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03783143 - Prevalence and Incidence of Lassa Virus Infection in Southern Mali | Biotech Hunter | Biotech Hunter